The National Medical Insurance Bureau reported the results of the three companies under Baiyun Mountain: Visating 87 kinds of drug prices, set up funds for commercial bribery

Today (August 9), the National Medical Bureau's public account issued the "Notice on the Price of Three Enterprises in Tianxin Pharmaceuticals and the Price of Pharmaceutical Price Package". Pharmaceutical Co., Ltd. (hereinafter referred to as Tianxin Pharmaceutical), Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd. Baiyunshan Pharmaceutical General Plant (hereinafter referred to as Baiyunshan Pharmaceutical General Plant), Guangzhou Baiyunshan Jingxiu Pharmaceutical Co., Ltd. (hereinafter referred to as Jingxiu Church) Three companies' drug virtual high prices and sets of funds for special investigations have further concluded.

After investigation, the above -mentioned enterprises and downstream drug agents colluded with each other to add the designated "dealers" in the procurement of the raw medicine drugs. The three companies purchased the raw medicine from the "dealer" at a high price. In this way, cash out funds for agents for medical business bribes. The report pointed out that excluding virtual high parts such as bribery in the current price, the average decrease in drugs by more than 50%.

"Daily Economic News" reporters found that in fact, the above three companies are Baiyunshan (SH600332, the stock price is 28.44 yuan, and the market value is 46.237 billion yuan). The work of the country is carried out, but Bai Yunshan has fallen into the "withdrawal of the net". Hundreds of medicines have been disqualified by the large -scale cancellation of procurement by multiple provinces. Non -pornographic citrate skeleton, at the time, media reported that it was "almost all troops in chemical sales."

Increase the "earning difference" of middlemen

According to the Baiyunshan annual report of 2021, Baiyunshan Pharmaceutical General Factory is Baiyunshan Branch, and Tianxin Pharmaceutical and Jingxiu Hall are subsidiaries directly controlled by Baiyunshan.

According to the report, from May 2017 to May 2021, three pharmaceutical manufacturers including Tianxin Pharmaceuticals in order to avoid the "two -vote system" policies and supervision, they colluded with more than 50 pharmaceutical agents in the lower reaches. The drugs were cash out by using virtual high -priced prices and transferred funds to downstream drug agents.

The main operation method of specific cash cash out is that drug manufacturers and drug agents sign a cooperation agreement. In the procurement of raw and drug procure Ten times are sold to drug manufacturers.

After this operation, pharmaceutical manufacturers will further transmit the virtual high price of the raw medicine to the factory and bidding network prices in the name of "raising prices and high production costs".

Taking cephalosporin sulfur sulfur as an example, Baiyunshan Pharmaceutical General Plant (referred to as preparation plant in this paragraph) and Baiyunshan Chemical Pharmaceutical Factory (hereinafter referred to as the raw material factory) belong to the same group, but the cephalosporin sulfur sulfur pillar medicine required by the preparation factory does not directly from the proceedings from the proofing plant. The group's raw material factory procurement is set up with an additional cash out process. The raw material drug "dealer" controlled by the agent is transferred to the preparation factory and cash off at low buying high. The preparation factory uses the high price of cephalosporin sulfurizer in the cost of the raw medicine drug, which makes the drug production and circulation link on the surface and other policies and regulations to avoid supervision.

"Daily Economic News" reporter noticed that in fact, the "dealer" of the raw medicine "dealers" was controlled by the drug agent, and the difference in income obtained by the low -selling and high -sale and high -selling raw medicines was cash to the drug agent for the latter for the latter to implement the pharmaceutical commerce business. bribe. The report stated that the above transfer funds involved huge amounts, and some of them were used to bribe medical staff or specific relations and carry out drug violations.

The report pointed out that Guangdong Province ordered three companies including Tianxin Pharmaceutical and other related companies to comprehensively rectify marketing models to stop relevant illegal operations. In addition, relevant departments are investigating and punishing in accordance with the law for those suspected of disciplinary, illegal, and crimes.

Since June this year, it has

"Daily Economic News" reporter noticed that the above incident can be described as a warning.

In June of this year, some varieties of Baiyunshan were eligible for drug hanging networks in many provinces. In addition to the amoxicillin series, cephalosporin sodium in injection, and "Viagra" citrus citrus pericide.

For example, the Shanxi Provincial Pharmaceutical Real Estate Bidding Purchase Center issued an announcement on June 14 showing that "application according to enterprises", three companies, including Baiyunshan, applied for a cancellation of 89 pharmaceutical product regulations on the platform hanging on the platform, and emphasized that this should be that this should be that this should be that this should be that this should be that this should be that this should be that this emphasizes that it is emphasized that it is emphasized that it is emphasized that it should be emphasized that it is emphasized that it is emphasized that The three companies' products have not accepted the product within two years after the withdrawal of the network.

Photo source: Screenshot

According to the Shanxi Provincial Announcement, the withdrawal of the nets of Jingxiu, Baiyunshan Pharmaceutical and Tianxin Pharmaceuticals, involved in the drug regulations, including citrate citrate slices, cephalosporin slices, and cephalosporin for injection. 89 drug regulations such as sodium sodium, clearing heat and anti -inflammatory capsules.

The announcement of Anhui Province's announcement seems to be tougher, and its announcement states that according to the requirements of the State Medical Insurance Bureau, the relevant drugs of Baiyunshan related drugs have been withdrawn and price rectification. Among them, the Jingxiu Hall, Baiyunshan Pharmaceutical General Plant and Tianxin Pharmaceutical Amoxicillin 229 drugs such as cephalosporin ester are listed.

Photo source: Screenshot of Anhui Pharmaceutical Concentrated Purchasing Platform

In addition, according to the relevant announcement of Guizhou Province, according to Baiyunshan's declaration, the price reduction or withdrawal of related drugs, Baiyunshan Pharmaceutical General Plant, Tianxin Pharmaceutical's citrate citrus tablets, cephalosporin ester tablets, and cephalosporin for injection, cephalosporin, and cephalosporin used33 pharmaceutical regulations such as Xinyan are ranked among the nets, and 43 pharmaceutical products such as amoxicillin and 哌laxin sodium are required to reduce prices.Relevant announcements in Shandong Province show that Baiyun Shan's drug withdrawal network reasons for drug discontinuation and duplicate products.On the afternoon of August 9, the reporter contacted the relevant person in the controlling shareholder of Baiyunshan's controlling shareholder Guangyao Group. As of the press time, the reply had not received a reply.

Cover picture source: Photo Network-500743910

Daily Economic News

- END -